ArticleNature2019
Publisher Correction: The metabolite BH4 controls T cell proliferation in autoimmunity and cancer.
Abstract readPublished Erratum
In one paragraph
Article in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Metabolic reprogramming in hepatocellular carcinoma: a bibliometric and visualized study from 2011 to 2023.Frontiers in pharmacology · 2024Pooled it
- Cardiovascular Toxicity in Cancer Therapy: Potential Mechanisms of Ferroptosis and Treatment Strategies.Cells · 2026Review
- Machine learning-based prediction of disease progression in primary progressive multiple sclerosis.Brain communications · 2025Article
- Identification of cervical squamous cell carcinoma feature genes and construction of a prognostic model based on immune-related features.BMC women's health · 2022Article
Corrections and comments
- Erratum for
Authors and funding
41 authors.
Shane J F CroninIMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Corey SeehusDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Adelheid WeidingerLudwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Center, Vienna, Austria.
Sebastien TalbotDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Sonja ReissigInstitute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Markus SeifertDepartment of Internal Medicine II (Infectious Diseases, Immunology, Rheumatology and Pneumology), Medical University of Innsbruck, Innsbruck, Austria.
Yann PiersonInstitute of Chemical Sciences and Engineering, Institute of Bioengineering, National Centre of Competence in Research (NCCR) in Chemical Biology, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Eileen McNeillDivision of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Maria Serena LonghiDivision of Gastroenterology and Liver Center, Department of Medicine, Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School (HMS), Harvard University, Boston, MA, USA.
Bruna Lenfers TurnesLABOX, Departamento de Bioquímica, Universidade Federal de Santa Catarina, Florianópolis, Brazil.
Taras KreslavskyResearch Institute of Molecular Pathology, Vienna Biocenter, Campus-Vienna-Biocenter 1, Vienna, Austria.
Melanie KoglerIMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
David HoffmannIMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Melita TicevicIMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Débora da Luz SchefferLABOX, Departamento de Bioquímica, Universidade Federal de Santa Catarina, Florianópolis, Brazil.
Luigi TortolaIMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Domagoj CikesIMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Alexander JaisDepartment of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany.
Manu RangachariDepartment of Neurosciences, Centre de Recherche de CHU de Québec-Université Laval, Québec, Québec, Canada.
Shuan RaoIMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Magdalena PaolinoKarolinska Institute, Department of Medicine Solna, Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
Maria NovatchkovaResearch Institute of Molecular Pathology, Vienna Biocenter, Campus-Vienna-Biocenter 1, Vienna, Austria.
Martin AichingerResearch Institute of Molecular Pathology, Vienna Biocenter, Campus-Vienna-Biocenter 1, Vienna, Austria.
Lee BarrettDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Alban LatremoliereNeurosurgery Department, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Gerald WirnsbergerApeiron Biologics AG, Vienna, Austria.
Guenther LametschwandtnerApeiron Biologics AG, Vienna, Austria.
Meinrad BusslingerResearch Institute of Molecular Pathology, Vienna Biocenter, Campus-Vienna-Biocenter 1, Vienna, Austria.
Stephen ZichaQuartet Medicine, 400 Technology Square, Cambridge, MA, USA.
Alexandra LatiniDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Simon C RobsonDivision of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Ari WaismanInstitute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Nick AndrewsDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Michael CostiganDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Keith M ChannonDivision of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Guenter WeissDepartment of Internal Medicine II (Infectious Diseases, Immunology, Rheumatology and Pneumology), Medical University of Innsbruck, Innsbruck, Austria.
Andrey V KozlovLudwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Center, Vienna, Austria.
Mark TebbeDepartment of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, Quebec, Canada.
Kai JohnssonInstitute of Chemical Sciences and Engineering, Institute of Bioengineering, National Centre of Competence in Research (NCCR) in Chemical Biology, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Clifford J WoolfDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA. clifford.woolf@childrens.harvard.edu.
Josef M PenningerIMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria. josef.penninger@imba.oeaw.ac.at.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Identifiers
PMID
31363232What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.